Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Acura Pharmaceuticals ( (ACUR) ) has issued an announcement.
On June 28, 2019, Acura Pharmaceuticals entered into a $6.0 million promissory note with John Schutte, which was later transferred to AD Pharma. By June 9, 2021, AD Pharma converted the note and accrued interest into 42,984,375 shares of Acura’s common stock. As of May 29, 2025, AD Pharma owns approximately 65% of Acura’s outstanding common stock, excluding a warrant for 10 million shares. The maturity date of a secured promissory note was extended to December 31, 2025, reflecting strategic financial adjustments.
More about Acura Pharmaceuticals
Average Trading Volume: 8,025
Technical Sentiment Signal: Sell
Current Market Cap: $1.32M
For detailed information about ACUR stock, go to TipRanks’ Stock Analysis page.